Glial Progenitor-Based Repair of Demyelinating Neurological Diseases

Neurosurgery Clinics of North America

Volumn 18, Issue 1, 2007, Pages 93-104

  Keyoung, H Michael ^a   Goldman, Steven A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLOPHOSPHAMIDE; GLATIRAMER; MITOXANTRONE; MYELIN; MYELIN BASIC PROTEIN; NATALIZUMAB; STEROID;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; BONE MARROW TRANSPLANTATION; CANAVAN DISEASE; CELL THERAPY; CENTRAL PONTINE MYELINOLYSIS; CEREBRAL PALSY; CHILDHOOD DISEASE; COCKAYNE SYNDROME; DEMYELINATING DISEASE; DEMYELINATION; DENTATE GYRUS; ENCEPHALOMALACIA; GLOBOID CELL LEUKODYSTROPHY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEUKODYSTROPHY; LIPOFUSCINOSIS; LYSOSOME STORAGE DISEASE; METACHROMATIC LEUKODYSTROPHY; MUCOPOLYSACCHARIDOSIS TYPE 7; MULTIPLE SCLEROSIS; MYELINATION; MYELITIS; NEURAL STEM CELL; NIEMANN PICK DISEASE; OLIGODENDROGLIA; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SANDHOFF DISEASE; SPASTICITY; SPINAL CORD INJURY; TAY SACHS DISEASE; WHITE MATTER;

ADULT STEM CELLS; ANIMALS; DEMYELINATING DISEASES; HUMANS; NEUROGLIA; STEM CELL TRANSPLANTATION;

EID: 33846475625     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2006.10.009     Document Type: Review

References (63)

1. Keirstead H. Stem cells for the treatment of myelin loss. Trends Neurosci 28 (2005) 677-683
2. Nieuwenhuys R., Voogd J., and Huijzen C. The human central nervous system (1988), Springer-Verlag, Berlin p. 365-75
3. Windrem M.S., Nunes M.C., Rashbaum W.K., et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 10 1 (2004) 93-97 [Epublication: December 21, 2003]
4. Goldman S. Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotechnol 23 7 (2005) 862-871
5. Bartzokis G., Lu P.H., and Mintz J. Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease. J Alzheimers Dis 6 Suppl (2004) S53-S59
6. Kovari E., Gold G., Herrmann F.R., et al. Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke 35 (2004) 410-414
7. Davis K.L., Stewart D.G., Friedman J.I., et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60 (2003) 443-456
8. Keyoung H.M., Roy N.S., Benraiss A., et al. High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain. Nat Biotechnol 19 9 (2001) 843-850
9. Goldman S. Adult neurogenesis: from canaries to the clinic. J Neurobiol 36 (1998) 267-286
10. Pincus D.W., Keyoung H.M., Harrison-Restelli C., et al. Fibroblast growth factor-2/brain-derived neurotrophic factor-associated maturation of new neurons generated from adult human subependymal cells. Ann Neurol 43 5 (1998) 576-585
11. Sanai N., Tramontin A.D., Quinones-Hinojosa A., et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427 6976 (2004) 740-744
12. Roy N.S., Wang S., Jiang L., et al. In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat Med 6 3 (2000) 271-277
13. Levine J.M., Reynolds R., and Fawcett J.W. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24 (2001) 39-47
14. Nunes M.C., Roy N.S., Keyoung H.M., et al. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 9 (2003) 439-447
15. Kondo T., and Raff M. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289 (2000) 1754-1757
16. Belachew S., Chittajallu R., Aguirre A.A., et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 161 1 (2003) 169-186
17. Windrem M.S., Roy N.S., Wang J., et al. Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res 69 6 (2002) 966-975
18. Roy N.S., Wang S., Harrison-Restelli C., et al. Identification, isolation, and promoter-defined separation of mitotic oligodendrocyte progenitor cells from the adult human subcortical white matter. J Neurosci 19 22 (1999) 9986-9995
19. Windrem M.S., Roy N., Nunes M., et al. Identification, selection and use of adult human oligodendrocyte progenitor cells. In: Zigova T., and Snyder E. (Eds). Neural stem cells for brain repair (2003), Humana, New York 69-88
20. Kaye E.M. Update on genetic disorders affecting white matter. Pediatr Neurol 24 1 (2001) 11-24
21. Back S., and Rivkees S. Emerging concepts in periventricular white matter injury. Semin Perinatol 28 6 (2004) 405-414
22. Powers J. The leukodystrophies: overview and classification. In: Lazzarini R.A. (Ed). Myelin biology and disorders (2004), Elsevier Academic Press, San Diego (CA) 663-690
23. Follett P., Deng W., Dai W., et al. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci Res 24 (2004) 4412-4420
24. Robinson S., Petelenz K., Li Q., et al. Developmental changes induced by graded prenatal systemic hypoxic-ischemic insults in rats. Neurobiol Dis 18 (2005) 568-581
25. Mitome M., Low H.P., van Den Pol A., et al. Towards the reconstruction of central nervous system white matter using neural precursor cells. Brain 124 (2001) 2147-2161
26. Yandava B.D., Billinghurst L.L., and Snyder E.Y. "Global" cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 96 (1999) 7029-7034
27. Suzuki K. Globoid cell leukodystrophy (Krabbe's disease): update. J Child Neurol 18 (2003) 595-603
28. Snyder E.Y., Taylor R.M., and Wolfe J.H. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 374 6520 (1995) 367-370
29. Urayama A., Grubb J.H., Sly W.S., et al. Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier. Proc Natl Acad Sci USA 101 34 (2004) 12658-12663 [Epublication: August 16, 2004]
30. Jeyakumar M., Dwek R., Butters T., et al. Storage solutions: treating lysosomal disorders of the brain. Nat Rev Neurosci 6 (2005) 1-12
31. Lacorazza H.D. Expression of human β-hexosaminidase a-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells. Nat Med 2 4 (1996) 424-429
32. Pellegatta S., Tunici P., Poliani P.L., et al. The therapeutic potential of neural stem/progenitor cells in murine globoid cell leukodystrophy is conditioned by macrophage/microglia activation. Neurobiol Dis 21 2 (2006) 314-323 [Epublication: September 30, 2005]
33. Pluchino S., Furlan R., and Martino G. Cell-based remyelinating therapies in multiple sclerosis: evidence from experimental studies. Curr Opin Neurol 17 3 (2004) 247-255
34. Pluchino S., Quattrini A., Brambilla E., et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422 6933 (2003) 688-694
35. Escolar M.L., Poe M.D., Provenzale J.M., et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med 352 20 (2005) 2069-2081
36. Krivit W., Peters C., and Shapiro E.G. Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III. Curr Opin Neurol 12 2 (1999) 167-176
37. Koc O.N., Day J., Nieder M., et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 30 4 (2002) 215-222
38. Givogri M.I., Galbiati F., Fasano S., et al. Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J Neurosci 26 12 (2006) 3109-3119
39. Compston A., and Coles A. Multiple sclerosis. Lancet 359 9313 (2002) 1221-1231
40. Weinshenker B.G., Bass B., Rice G.P., et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112 Pt 1 (1989) 133-146
41. Cottrell D.A., Kremenchutzky M., Rice G.P., et al. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 122 Pt 4 (1999) 641-647
42. Rizvi S.A., and Agius M.A. Current approved options for treating patients with multiple sclerosis. Neurology 63 12 Suppl. 6 (2004) S8-S14
43. Fox E.J. Management of worsening multiple sclerosis with mitoxantrone: a review. Clin Ther 28 4 (2006) 461-474
44. Langer-Gould A., Atlas S.W., Green A.J., et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353 4 (2005) 375-381 [Epublication: June 9, 2005]
45. Burt R.K., Fassas A., Snowden J., et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 28 1 (2001) 1-12
46. Saiz A., Carreras E., Berenguer J., et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS. Neurology 56 8 (2001) 1084-1089
47. Fassas A., and Kimiskidis V.K. Stem cell transplantation for multiple sclerosis: what is the evidence?. Blood Rev 17 4 (2003) 233-240
48. h2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells. Int Immunol 12 (2000) 57-66
49. Zhang X., Brunner T., Carter L., et al. Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis. J Exp Med 185 (1997) 1837-1849
50. Hardison J.L., Nistor G., Gonzalez R., et al. Transplantation of glial-committed progenitor cells into a viral model of multiple sclerosis induces remyelination in the absence of an attenuated inflammatory response. Exp Neurol 197 2 (2006) 420-429 [Epublication: November 17, 2005]
51. Pluchino S., Zanotti L., Rossi B., et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436 7048 (2005) 266-271
52. Franklin R.J. Why does remyelination fail in multiple sclerosis?. Nat Rev Neurosci 3 9 (2002) 705-714
53. Han S.W., Liu Y., Tyler-Polsz C., et al. Transplantation of glial-restricted precursor cells into the adult spinal cord. Glia 45 (2004) 1-16
54. Nistor G.I., Totoiu M.O., Haque N., et al. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 49 3 (2005) 385-396
55. Brustle O., Jones K.N., Learish R.D., et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 285 5428 (1999) 754-756
56. Wang X., Arcuino G., Takano T., et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10 8 (2004) 821-827 [Epublication: July 18, 2004]
57. Pearse D., Pereira F., Marcillo A., et al. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat Med 10 (2004) 610-616
58. Goldman S. Directed mobilization of endogenous neural progenitor cells: the intersection of stem cell biology and gene therapy. Curr Opin Mol Ther 6 (2004) 466-472
59. Sim F.J., and Goldman S.A. White matter progenitor cells reside in an oligodendrogenic niche. Ernst Schering Res Found Workshop 53 (2005) 61-81
60. Sim F.J., Lang J.K., Waldau B., et al. Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation. Ann Neurol 59 5 (2006) 763-779
61. Alvarez-Buylla A., and Garcia-Verdugo J.M. Neurogenesis in adult subventricular zone. J Neurosci 22 (2002) 629-634
62. Einheber S., Zanazzi G., Ching W., et al. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J Cell Biol 139 6 (1997) 1495-1506
63. Goldman S.A., Lang J., Roy N.S., et al. Progenitor cell-based myelination as a model for cell-based therapy of the CNS. Ernst Schering Foundation Symposium. In: Morser J., Nishikawa S.-I., and Schoeler H. (Eds). Stem cells in reproduction and the brain, vol. 60 (2006), Springer-Verlag, Berlin 195-213